Arteris COO sells 1,420 shares under 10b5-1 plan
Arteris, Inc. Chief Operating Officer Moll Laurent R reported a small insider sale of common stock.
Rhea-AI Filing Summary
Arteris, Inc. Chief Operating Officer Moll Laurent R reported a small insider sale of common stock. On January 6, 2026, the executive sold 1,420 shares at a price of $16.23 per share. After this transaction, Moll Laurent R directly held 250,573 shares of Arteris common stock. The sale was made under a Rule 10b5-1 trading plan that the reporting person adopted on March 12, 2025, indicating it was pre-arranged rather than a discretionary market-timed trade.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,420 | $16.23 | $23K |
Footnotes (1)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2025.
FAQ
What insider transaction did Arteris (AIP) report in this Form 4?
The filing reports that Chief Operating Officer Moll Laurent R sold 1,420 shares of Arteris, Inc. common stock on January 6, 2026.
What is the role of Moll Laurent R at Arteris (AIP)?
Moll Laurent R is an officer of Arteris, Inc., serving as the company’s Chief Operating Officer, and is the reporting person on this Form 4.
Was the Arteris (AIP) insider sale made under a Rule 10b5-1 trading plan?
Yes. A footnote explains that the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025.
Is this Arteris (AIP) Form 4 filing for direct or indirect ownership?
The Form 4 states that the 250,573 shares held after the transaction are owned directly by the reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.